首页> 美国卫生研究院文献>other >Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines
【2h】

Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines

机译:MDCK细胞无血清悬浮培养用于生产H1N1流感疫苗。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Development of serum-free suspension cell culture processes is very important for influenza vaccine production. Previously, we developed a MDCK suspension cell line in a serum-free medium. In the present study, the growth kinetics of suspension MDCK cells and influenza virus production in the serum-free medium were investigated, in comparison with those of adherent MDCK cells in both serum-containing and serum-free medium. It was found that the serum-free medium supported the stable subculture and growth of both adherent and suspension cells. In batch culture, for both cell lines, the growth kinetics in the serum-free medium was comparable with those in the serum-containing medium and a commercialized serum-free medium. In the serum-free medium, peak viable cell density (VCD), haemagglutinin (HA) and median tissue culture infective dose (TCID50) titers of the two cell lines reached 4.51×106 cells/mL, 2.94Log10(HAU/50 μL) and 8.49Log10(virions/mL), and 5.97×106 cells/mL, 3.88Log10(HAU/50 μL), and 10.34Log10(virions/mL), respectively. While virus yield of adherent cells in the serum-free medium was similar to that in the serum-containing medium, suspension culture in the serum-free medium showed a higher virus yield than adherent cells in the serum-containing medium and suspension cells in the commercialized serum-free medium. However, the percentage of infectious viruses was lower for suspension culture in the serum-free medium. These results demonstrate the great potential of this suspension MDCK cell line in serum-free medium for influenza vaccine production and further improvements are warranted.
机译:开发无血清悬浮细胞培养方法对于生产流感疫苗非常重要。以前,我们在无血清培养基中开发了MDCK悬浮细胞系。在本研究中,与含血清和无血清培养基中的贴壁MDCK细胞相比,研究了无血清培养基中MDCK悬浮细胞的生长动力学和流感病毒的产生。发现无血清培养基支持粘附细胞和悬浮细胞的稳定继代培养和生长。在分批培养中,对于两种细胞系,无血清培养基中的生长动力学与含血清培养基和商业化的无血清培养基中的生长动力学相当。在无血清培养基中,两个细胞系的峰值活细胞密度(VCD),血凝素(HA)和中位组织培养感染剂量(TCID50)滴度达到4.51×10 6 个细胞/ mL, 2.94Log10(HAU / 50μL)和8.49Log10(virions / mL),以及5.97×10 6 细胞/ mL,3.88Log10(HAU / 50μL)和10.34Log10(virions / mL) , 分别。尽管无血清培养基中贴壁细胞的病毒产量与含血清培养基中的相似,但无血清培养基中的悬浮培养显示的病毒产量要高于含血清培养基中的贴壁细胞和无血清培养基中的悬浮细胞。商业化的无血清培养基。但是,在无血清培养基中悬浮培养的感染性病毒百分比较低。这些结果证明了在无血清培养基中的该悬浮MDCK细胞系在流感疫苗生产中的巨大潜力,并且有待进一步改进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号